This page is dedicated to industry-related funds that may be available to UCLA researchers. Please see below for the deadlines, fund amounts and details.
Year Round
AMGEN - Ongoing - Award Amount Varies
| Summary | In support of our mission, the Amgen Foundation seeks to improve access and advance excellence in science education to inspire the next generation of innovators, as well as invest in strengthening communities where Amgen staff members live and work. We support a broad variety of organizations whose philosophies, objectives, and approaches align with the Foundation's mission and strategic goals. Each year, the Foundation awards grants to local, regional, and international nonprofit organizations whose programs are replicable, scalable and designed to have a lasting and meaningful effect in Amgen communities. These grants reflect Amgen's dedication to impacting lives in inspiring and innovative ways. |
| Funding | Varies |
| Themes | Bone, cardiovascular, inflammation, hematology/oncology, neurology, nephrology, rare disease |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu (will be forwarded to appropriate RIA Officer/BDO |
| AMGEN Grants |
Abbvie - Ongoing - Award Amount Varies
| Summary | The AbbVie IIS Program provides an opportunity for academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support. |
| Funding | product or funding award / varies per award |
| Themes | AbbVie products/therapeutic areas (aesthetics, eye care, immunology, neuroscience, oncology, specialty) |
| Deadline | Rolling submission via online portal |
| Contact | info@tdg.ucla.edu |
| Abbvie (IIS) | |
Amazon - Research Awards (ARA) - Ongoing (Annual) - Amount Varies
| Summary | "Awards are structured as unrestricted gifts to the principal investigator's academic institution or organization and as such, Amazon retains no intellectual property rights to the resulting work. Recipients are encouraged to publish outcomes and commit related code to open-source repositories. Recipients are assigned an Amazon research contact who offers consultation and advice along with opportunities to participate in Amazon events and training sessions." |
| Funding | unrestricted funds + AWS promotional credits (amount varies) |
| Themes | area posted per call (e.g. AI/ML, security, sustainability, etc.) |
| Deadline | Quarterly - Ongoing |
| Contact | info@tdg.ucla.edu |
| Amazon Research Awards |
Astrazeneca Open Innovation - Ongoing - Award Varies
| Summary | "Through our Open Innovation programme, we share our compounds, tools, technologies and expertise with the scientific community to advance drug discovery and development." |
| Funding | Collaboration agreements, material access (compounds, tools, technologies, and expertise), potential funding depending on opportunity |
| Themes | Clinical (molecules, human samples, translational data), pre-clinical (drug delivery, cell therapy, etc), sustainability, CoSolve challenges |
| Deadline | Program Specific (see link to program below) |
| Contact | info@tdg.ucla.edu |
| AstraZeneca Open Innovation |
Bausch + Lomb (IIT) - Ongoing - Amount Varies
| Summary | Bausch + Lomb Investigator Initiated Trials |
| Funding | Varies/TBD |
| Themes | Pharmaceuticals, Surgical, Vision Care |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu |
| BAUSCH + LOMB (IIT) |
Boston Scientific - Ongoing - Amount Award Varies
| Summary | Boston Scientific is committed to generating and supporting research that furthers the understanding of diseases and their treatment with the ultimate goal of transforming patients’ lives. This global ISR grant program is open to qualified researchers who are interested in conducting research that addresses evidence gaps and unmet needs that are of interest to Boston Scientific and the medical community. This program is designed to support independent research initiated and conducted by investigators or institutions external to Boston Scientific as the study sponsor. |
| Funding | Varies |
| Themes | Endoscopy, interventional cardiology/structural heart, interventional oncology & embolization, neuromodulation, peripheral interventions – vascular and arterial, rhythm & electrophysiology, urology |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu (will be forwarded to appropriate RIA Officer/BDO |
| BSC ISR Program |
Biogen- (IIT) or (CR) - Quarterly - Award Varies
| Summary | "We continuously strive to improve our submission process and provide necessary guidance to investigators. The information below will help you develop and plan your proposal for submission." |
| Funding | Funding, study drug, medical writing, data management, statistical analysis, or access to Biogen data sets and banked lab samples |
| Themes | Rare diseases, multiple sclerosis, neuropsychiatry |
| Deadline | Proposals reviewed on a quarterly basis |
| Contact | info@tdg.ucla.edu |
| Biogen IIT/IIR |
Bristol Myers Squibb (BMS) - Ongoing (RFP Cycle) - Amount Varies
| Summary | "We are currently accepting concepts for the following therapeutic areas. BMS periodically opens RFP Cycles across different therapeutic areas and the pre-concept submission periods will be posted below when available. We strongly encourage all applicants to begin the online application process early to allow adequate time for completion. For a submission to qualify for review, all information including any required uploads must be submitted through the application form prior to the specified end dates for the RFP Cycle." |
| Funding | Grant funding; sometimes with data/resources |
| Themes | No current areas of interest posted, but will be updated with RFP cycles |
| Deadline | Specific to RFP Cycles |
| Contact | info@tdg.ucla.edu |
| Bristol Myers Squibb (BMS) |
Cisco RFPs - Periodic - Award Amount Varies
| Summary | Open RFPs |
| Funding | Gift funding or sponsored research in specific RFP topics / award varies |
| Themes | Generative AI, web assembly, sustainability, AR and VR, NLP, cybersecurity, quantum computing, etc. |
| Deadline | Updates to be made in September 2025 (see website) |
| Contact | info@tdg.ucla.edu |
| Cisco RFP |
CooperVision Investigator Initiated Studies (IIS) - Varies/ in Kind
| Summary | CooperVision is dedicated to raising the bar on product excellence and creating the next generation of contact lenses. To help achieve this, CooperVision maintains a strong commitment to help support ethical, relevant research by qualified investigators. Investigator Initiated Studies (IIS) are independent proposals from external research partners which may provide valuable scientific and clinical information on contact lens wear and associated topics, and these may include CooperVision products. For such proposals of scientific merit or interest to the business, CooperVision may be able to provide support for these research projects, either through monetary funding and/or the provision of contact lenses. |
| Funding | Varies / In-kind |
| Themes | Contact Lens Wear |
| Deadline | Rolling via online portal |
| Contact | info@tdg.ucla.edu |
| CooperVision (IIS) |
Eli Lilly (LRAP) - Ongoing - Award Varies
| Summary | The Lilly Research Award Program (LRAP) provides Lilly scientists who are working on basic and applied research projects with an avenue to partner with global external researchers to collaboratively advance research projects. These research projects range in focus and may include development of new models, methods, or techniques, validation of disease targets and/or biomarkers, or approaches to improve existing preclinical models. |
| Funding | Grant funding (varies); for LRAP, multi-month sponsored research per guidelines. |
| Themes | Immunology, endocrine, neuroscience, oncology |
| Deadline | Grant Office portal open year-round; LRAP by internal initiation + joint proposal |
| Contact | info@tdg.ucla.edu |
| Eli Lilly Research Award Program |
Gilead - Externally Sponsored Research - Ongoing - Award Amount Varies
| Summary | "We are committed to generating and supporting critical, high-quality research that has an impact on clinical decision-making and patients’ lives. Our externally sponsored research program provides funding and/or study drug support for research efforts conducted by third parties on Gilead products or therapeutic areas." |
| Funding | Varies |
| Themes | Virology & infectious diseases, oncology, inflammation |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu |
| Gilead ESP |
GSK - Supported Studies Programme - Ongoing - Amount Varies
| Summary | "At GSK, we are dedicated to improving the quality of human life by enabling people to do more, feel better and live longer. As part of this commitment, we recognise the valuable role that Supported Studies (Investigator-Sponsored Studies (ISS) and Supported Collaborative Studies (SCS)) play in fulfilling this mission." |
| Funding | Grant funding and/or study drug depending on the proposal |
| Themes | Vaccines, specialty, general medicines oncology, ViiV, global health |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu |
| GSK - Supported Studies Programme | |
IBM Faculty Awards & PhD Fellowship - July-August (Annually) - $40K / Varies
| Summary | IBM PhD Fellowship and IBM Faculty Awards promote research, innovation, and the building of social, scientific, and technology-based collaboration with universities. The award programs are designed to support a spectrum of university needs: The highly competitive IBM PhD Fellowship Awards provide funding for PhD students in the final years of their PhD program, and the IBM Faculty Awards program provides support to individual faculty in broader areas of emerging science and technology that are of significant interest to the university and IBM. |
| Funding | o Faculty Award: Varies o PhD Fellowship: $40,000 / 1 year |
| Themes | various areas of emerging science and technology of interest to IBM (semiconductor technology, quantum computing, security, exploratory AI science, foundation models and large language models, trustworthy AI, responsible computing) |
| Deadline | o Faculty Awards: not specified – require nomination by IBM employees o PhD Fellowship: July-August / Annual Call |
| Contact | info@tdg.ucla.edu |
| IBM FACULTY AWARDS |
Intel - University Research Programs - Quarterly - Award Amount Varies
| Summary | "As an active education supporter and trusted industry partner, Intel works closely with everyone involved in the educational ecosystem to help shape the future of education technology, drive innovation in education, and deliver equitable EdTech solutions that meet the needs of all students—no matter how or where they learn." |
| Funding | Varies |
| Themes | strategic areas across Intel’s roadmap |
| Deadline | Proposals reviewed quarterly |
| Contact | info@tdg.ucla.edu |
| Intel Research Programs |
Johnson & Johnson - JLABS - Ongoing - $100K - $300K
| Summary | "Johnson & Johnson leverages the QuickFire Challenge crowdsourcing platform to help identify, empower and enable potential breakthrough healthcare ideas from innovators across the globe. Innovators – including entrepreneurs, companies at all stages of development, researchers and students – are invited to apply." |
| Funding | Funding (~$100-300K) + mentorship and JLABS support |
| Themes | Oncology, MedTech/surgery, neuroscience, immunology, etc |
| Deadline | Ongoing |
| Contact | info@tdg.ucla.edu |
| Johnson & Johnson - JLABS | |
Johnson & Johnson MedTech - Ongoing - Award Amount Varies
| Summary | Investigator Initiated Study (IIS) grant requests. The company supports unique, non-duplicative, independent clinical research studies of scientific and business merit with grants providing either funding and/or product(s). Submissions will only be accepted from study personnel. |
| Funding | Varies |
| Themes | Bariatric, stroke, cardiology, ortho, vision and more please visit site for full list |
| Deadline | Ongoing |
| Contact | info@tdg.ucla.edu (will be forwarded to appropriate RIA Officer/BDO) |
| Johnson & Johnson Medtech IIS Grants |
Medtronic External Research Program - Ongoing - Award Varies
| Summary | The Medtronic External Research Program supports a global network of investigator-sponsored research projects in the spirit of advancing scientific and clinical knowledge related to our products and therapies, with the goal of improving patient care and clinical outcomes. |
| Funding | Funding (application-specific) or products |
| Themes | Released in 2025 or via contact at erp@medtronic.com |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu |
| Medtronic External Research Program |
Merck ISP - Ongoing - Award Amount Varies
| Summary | The company Investigator Studies Program (MISP) aims to advance science and improve patient care by supporting, through the provision of drug/vaccine and/or total/partial funding, high-quality research that is initiated, designed, implemented, and sponsored by external investigators. Results will be generated and properly disseminated in peer-reviewed publications. |
| Funding | Varies |
| Themes | Oncology, ID/vaccines, general and specialty medicine (cardiolog, immunology, neuroscience, obesity, etc. |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu (will be forwarded to appropriate RIA Officer/BDO |
| MISP Program |
Microsoft - Investigator & Faculty Fellowship - Periodic - $100K Annually for 2yrs
| Summary | o Investigator Fellowship: Full time faculty member in US, hold PhD, currently conducting research, advising graduate students, and teaching in a classroom + using or planning to use Microsoft Azure in research/teaching o Faculty Fellowship: New faculty nominated by university of Microsoft nominator - must be full time faculty in North or South America, received terminal degree in May 2017 or later, currently conducting research, advising graduate students, and teaching in classroom |
| Funding | o Investigator Fellowship: $100,000 annually for 2 years o Faculty Fellowship: $100,000 annually for 2 years |
| Themes | Intelligence, systems, theory, + other (medical, health & genomics, etc) |
| Deadline | Periodic cycles announced on website |
| Contact | info@tdg.ucla.edu |
Novartis - (IIT/IIR) - Ongoing - Amount Varies
| Summary | "We welcome unsolicited research proposals from qualified investigators in our strategic areas of interest which we list below. Well-thought through studies that enhance our delivery of innovative therapies to more patients worldwide, enhance patient care, and align with our strategic areas of interest will be considered." |
| Funding | Funding and/or drug supply / amount varies |
| Themes | oncology, CRM, neuroscience, gene therapy, immunology |
| Deadline | Rolling applications |
| Contact | info@tdg.ucla.edu |
| Novartis (IIT/IIR) | |
NVIDIA - Academic Grant Programs - Ongoing - Amount Varies
| Summary | The NVIDIA Academic Grant Program advances academic research by providing world-class computing access and resources to researchers. |
| Funding | Amount varies |
| Themes | Generative AI, robotics – must be accelerated with NVIDIA technology |
| Deadline | Rolling applications via portal |
| Contact | info@tdg.ucla.edu |
| NVIDIA - Academic Grant Programs |
Oracle for Research - Ongoing - Oracle Cloud Credits
| Summary | Oracle for Research |
| Funding | Oracle Cloud credits |
| Themes | Cloud-enabled research across disciplines |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu |
| Oracle for Research |
Pfizer - Ongoing - Award Amount Varies
| Summary | Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. |
| Funding | Varies |
| Themes | Multiple therapeutic areas (oncology, vaccines, inflammation, rare disease, etc) |
| Deadline | Rolling |
| Contact | info@tdg.ucla.edu (will be forwarded to appropriate RIA Officer/BDO |
| Pfizer Grants |
Qualcomm - November-December (Annually) - $100K
| Summary | "We believe that research and development is the key to harnessing the power of imagination and to discovering new possibilities. We are excited to announce a new kind of Fellowship that promotes Qualcomm’s core values of innovation, execution and teamwork. Our goal is to enable students to pursue their futuristic innovative ideas." |
| Funding | $100,000 per team + mentorship / 1 year |
| Themes | Advanced semiconductor electronics, advances in communication techniques and theory, autonomous driving, AI and machine learning, multimedia computing, secure system design, SoC and hardware design, system architecture |
| Deadline | Application Open November-December Annually |
| Contact | info@tdg.ucla.edu |
| Qualcomm Innovation Fellowship |
Roche / Genentech Investigator-Initiated Studies (IIS) - Ongoing - Award Varies
| Summary | "Investigator initiated clinical studies can play a key role in answering important medical and scientific questions regarding Roche’s products and their related therapeutic areas. Such clinical studies can contribute towards enhancing the understanding of Roche’s products and their appropriate application, thus improving patient care, and sparking new ideas for further disease-related research aimed at creating improved treatment for patients." |
| Funding | Funding and/or materials, medicine, and/or information |
| Themes | Clinical studies of Roche drugs/diagnostic assays, medical devices and solutions, clinical observational studies, studies allowing the use of biobanks or sample collection, health economics evaluations and analytical studies |
| Deadline | Rolling submission via online portal |
| Contact | info@tdg.ucla.edu |
| Roche/Genentech IIS |
Samsung LEAP-U - Ongoing - Award Amount Varies
| Summary | LEAP‑U—short for "Leveraging Entrepreneurship to Accelerate Partnerships with Universities"—is an incubation initiative by Samsung Research America (SRA) focused on advancing later-stage university research toward commercialization. |
| Funding | Submit a budget. Acceptable personnel costs may include salaries for professor, faculty researchers, and postdocs, as well as stipends related to graduate or undergraduate student participation in the project. |
| Theme | Medical Technology and Robotics |
| Deadline | Ongoing |
| Contact | info@tdg.ucla.edu |
| SAMSUNG LEAP-U |
Samsung GRO - June-August/Annually - $150K /YR
| Summary | GRO (Global Research Outreach) |
| Funding | Up to $150K / 1 year with possible renewal |
| Themes | System architecture, New computing, Semiconductor materials, Semiconductor metrology, Next generation catalysts, Environment tech |
| Deadline | Submission June 23, 2025 - August 29, 2025 |
| Contact | info@tdg.ucla.edu |
| SAMSUNG GRO |
Samsung START - February-March (Annually) - $150K/YR
| Summary | START (STrategic Alliance for Research and Technology) |
| Funding | Up to $150K / 1 year with possible renewal |
| Themes | Artificial Intelligence, Digital Health, 6G, Camera, Multimedia, AR / VR, Security, System on Chip, Big Data, Robotics, Medical Tech, New Emerging Tech |
| Deadline | Abstract submission February - March / Annual call |
| Contact | info@tdg.ucla.edu |
| SAMSUNG START |
Sanofi - December/Annual - Seed $150K / Varies
| Summary | IDEA-TECH Seed funding of $150.000 USD Investigator Sponsored Studies Investigator Sponsored Studies are defined as unsolicited research originating from an external sponsor entity, institution or organization and include studies also known as investigator sponsored trials (IST), expert initiated research (EIR) or any other term which may reference investigator sponsored or investigator-initiated research. |
| Funding | o iDEA-TECH: seed funding of $150K / 1 year o Investigator Sponsored Studies: Varies by proposal |
| Themes | o iDEA-TECH: Developing new technologies to improve lives (examples: drug target enabling platforms, test new digital/AI solutions, high throughput screening, etc.) o Investigator Sponsored Studies: Autoimmune Type 1 Diabetes, Dyslipidemia, Dermatology, Diabetes, Immunolog, Neurology, Oncology, Rare Blood Disorder, Rare Disease, Transplant, Vaccines |
| Deadline | o iDEA-TECH: Opens in December / Annual submission o Investigator Sponsored Studies: Continuous submission |
| Contact | info@tdg.ucla.edu |
Takeda (IIR) - Ongoing - Award Varies
| Summary | "We, along with our partner network, are committed to improving patient care through support of scientific advances in medicine and increasing understanding of important diseases. Our Investigator Initiated Research (IIR) program supports innovative clinical and basic science studies that address important medical and scientific questions related to our compounds and therapeutic areas of interest." |
| Funding | Study drug and/or funding |
| Themes | Transplant, hereditary angioedema, gastroenterology, neuroscience, rare hematology, rare metabolic diseases, plasma derived therapies, oncology, vaccines |
| Deadline | Rolling via online portal |
| Contact | info@tdg.ucla.edu |
| Takeda (IIR) |
October
November
GenScript: Life Science Research Grant Program - 11/15 - Up to $100,000
| Summary | GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services. |
| Funding | Up to $100,000 |
| Themes | Gene and Cell Therapy Development, Antibody Drug Discovery, AI Drug Discovery, Vaccine Development, Diagnostics |
| Deadline | November 15 |
| Contact | info@tdg.ucla.edu |
| GenScript: Life Science Research Grant Program |